Form D · Biotechnology
Polyrizon Ltd.
Raanana, L3 · CIK 0001893645
Offering snapshot reported Sep 10, 2026 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 10, 2026 | Initial | $3,999,996 | No comparison | 1 | SEC filing |
| Apr 23, 2026 | Initial | $3,499,992 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $320K
- Finders' fees
- $0
- Form D file number
- 021-597061
The warrants and shares were issued in connection with (i) a registered direct offering of 232,500 shares and pre-funded warrants for 30,000 shares, and (ii) a private placement of pre-funded warrants for 70,833 shares and warrants for 333,333 shares.
Aegis Capital Corp. is entitled to a cash placement fee equal to 8.0% of the gross proceeds received in the offering and $75,000 for reasonable legal fees and disbursements for its counsel.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corp. | 000015007 |
Source: Form D, filed Sep 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Oz Adler | Director |
| Liron Carmel | Director |
| Asaf Itzhaik | Director |
| Tomer Izraeli | Director, Executive |
| Eyal Ron | Executive |
| Liat Sidi | Director |
| Tidhar Turgeman | Executive |
| Yehonatan Zalman Vinokur | Director |
| Nir Ben Yosef | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8 Hapnina Street
Raanana, L3, 4321545
Phone: +972-9-3740120
Raanana, L3, 4321545
Phone: +972-9-3740120